Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
OMEPRAZOLE
PRO DOC LIMITEE
A02BC01
OMEPRAZOLE
20MG
CAPSULE (DELAYED RELEASE)
OMEPRAZOLE 20MG
ORAL
100/500
Prescription
PROTON-PUMP INHIBITORS
Active ingredient group (AIG) number: 0121643001; AHFS:
APPROVED
2010-02-05
_OMEPRAZOLE (Omeprazole delayed-release capsules) _ _Page 1 of 49 _ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR OMEPRAZOLE Omeprazole Delayed-Release Capsules Capsules (delayed release), 20 mg, Oral Manufacturer’s Standard Proton Pump Inhibitor PRO DOC LTÉE 2925 boul. Industriel Laval, Québec H7L 3W9 Submission Control Number: 279464 Date of Initial Authorization: FEB 05, 2010 Date of Revision: OCT 13, 2023 _OMEPRAZOLE (Omeprazole delayed-release capsules) _ _Page 2 of 49 _ RECENT MAJOR LABEL CHANGES Not applicable. TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED. RECENT MAJOR LABEL CHANGES ........................................................................................... 2 TABLE OF CONTENTS ............................................................................................................. 2 PART I: HEALTH PROFESSIONAL INFORMATION ..................................................................... 4 1 INDICATIONS .............................................................................................................. 4 1.1 Pediatrics ................................................................................................................. 4 1.2 Geriatrics ................................................................................................................. 4 2 CONTRAINDICATIONS ................................................................................................. 4 4 DOSAGE AND ADMINISTRATION ................................................................................. 4 4.1 Dosing Considerations ............................................................................................. 4 4.2 Recommended Dose and Dosage Adjustment ....................................................... 5 4.4 Administration ......................................................................................................... 7 4.5 Missed Dose ........................................... Կարդացեք ամբողջական փաստաթուղթը